CN114904402B - A layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application - Google Patents
A layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application Download PDFInfo
- Publication number
- CN114904402B CN114904402B CN202210613901.2A CN202210613901A CN114904402B CN 114904402 B CN114904402 B CN 114904402B CN 202210613901 A CN202210613901 A CN 202210613901A CN 114904402 B CN114904402 B CN 114904402B
- Authority
- CN
- China
- Prior art keywords
- separation membrane
- layer
- polymer separation
- solution
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 156
- 238000000926 separation method Methods 0.000 title claims abstract description 69
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 47
- 229920000642 polymer Polymers 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims abstract description 48
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 26
- 239000005017 polysaccharide Substances 0.000 claims abstract description 26
- 229920002873 Polyethylenimine Polymers 0.000 claims abstract description 21
- 239000011259 mixed solution Substances 0.000 claims abstract description 8
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 3
- 150000004676 glycans Chemical class 0.000 claims abstract 12
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 68
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 68
- 239000000243 solution Substances 0.000 claims description 63
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 32
- 239000000661 sodium alginate Substances 0.000 claims description 32
- 235000010413 sodium alginate Nutrition 0.000 claims description 32
- 229940005550 sodium alginate Drugs 0.000 claims description 32
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 28
- 239000002033 PVDF binder Substances 0.000 claims description 26
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 18
- 229960003638 dopamine Drugs 0.000 claims description 14
- 238000013268 sustained release Methods 0.000 claims description 9
- 239000012730 sustained-release form Substances 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 5
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- 239000001263 FEMA 3042 Substances 0.000 claims description 2
- 101800004761 Magainin-2 Proteins 0.000 claims description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 2
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 2
- 229960000633 dextran sulfate Drugs 0.000 claims description 2
- MGIUUAHJVPPFEV-ABXDCCGRSA-N magainin ii Chemical compound C([C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 MGIUUAHJVPPFEV-ABXDCCGRSA-N 0.000 claims description 2
- 108010022457 polysaccharide peptide Proteins 0.000 claims description 2
- 229920002258 tannic acid Polymers 0.000 claims description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 2
- 229940033123 tannic acid Drugs 0.000 claims description 2
- 235000015523 tannic acid Nutrition 0.000 claims description 2
- 108050004290 Cecropin Proteins 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 241001122767 Theaceae Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000001338 self-assembly Methods 0.000 abstract description 21
- -1 polyphenol compound Chemical class 0.000 abstract description 7
- 241000894006 Bacteria Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000004048 modification Effects 0.000 abstract description 4
- 238000012986 modification Methods 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 3
- 230000009881 electrostatic interaction Effects 0.000 abstract description 2
- 238000001179 sorption measurement Methods 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000035699 permeability Effects 0.000 description 16
- 150000004804 polysaccharides Chemical class 0.000 description 14
- 239000008367 deionised water Substances 0.000 description 12
- 229910021641 deionized water Inorganic materials 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 10
- 230000008961 swelling Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000007974 sodium acetate buffer Substances 0.000 description 5
- 239000012535 impurity Substances 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229920001046 Nanocellulose Polymers 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700022013 Insecta cecropin B Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000011041 water permeability test Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/30—Polyalkenyl halides
- B01D71/32—Polyalkenyl halides containing fluorine atoms
- B01D71/36—Polytetrafluoroethene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0006—Organic membrane manufacture by chemical reactions
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/48—Antimicrobial properties
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A20/00—Water conservation; Efficient water supply; Efficient water use
- Y02A20/124—Water desalination
- Y02A20/131—Reverse-osmosis
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Abstract
Description
技术领域Technical field
本发明涉及一种层层自组装的缓释抗菌聚合物分离膜及其制备方法和应用,属于水处理技术领域。The invention relates to a layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application, and belongs to the technical field of water treatment.
背景技术Background technique
膜分离技术具有工艺简单、能耗低、绿色高效等特点,已经被广泛应用于水处理领域。但是膜的污染问题仍然是膜分离技术发展的主要障碍,尤其是由分离料液中的细菌在膜表面粘附滋生造成的生物污染,严重影响膜分离效率和运行寿命。因此,寻找一种性能优良、可长效抗菌抗污染的分离膜的制备方法已经成为现阶段膜制备领域研究的热点。Membrane separation technology has the characteristics of simple process, low energy consumption, green and high efficiency, and has been widely used in the field of water treatment. However, membrane pollution is still a major obstacle to the development of membrane separation technology, especially biological pollution caused by the adhesion and growth of bacteria in the separation liquid on the membrane surface, which seriously affects membrane separation efficiency and operating life. Therefore, finding a preparation method for a separation membrane with excellent performance, long-term antibacterial and anti-pollution properties has become a hot topic in the field of membrane preparation at this stage.
层层自组装是利用逐层交替沉积的方法,借助分子间的弱相互作用(如静电引力、氢键、配位键等),使层与层之间自发地结合形成结构完整、性能稳定、具有某种特定功能的分子聚集体或超分子结构的过程。层层自组装制备方法简单,制备过程不需要复杂的设备;成膜物质丰富,聚电解质材料既可以是天然蛋白质、纤维素、多糖类组织,也可以是人工合成的高分子聚合物。另外,其条件可控,组装过程不受基材大小和材料的控制,可在分子水平控制组装体系的结构和性质。例如,发明专利公开CN 113731190 A通过层层自组装法以纳米纤维素为制膜基元构筑了具有亲水表面的纳米纤维素膜材料;发明专利公开CN114292428 A通过层层自组装的方法将可负载疏水性抗菌活性物质的梳状聚合物季铵化纤维素纳米晶体与纤维素纳米纤维-壳聚糖基层进行复合,制备的抗菌膜具有一定的力学性能和阻隔性能。但以上制备方法改性过程复杂、长期稳定性较差,不利于商业化生产。Layer-by-layer self-assembly uses the method of alternate deposition layer by layer, with the help of weak interactions between molecules (such as electrostatic attraction, hydrogen bonds, coordination bonds, etc.), to spontaneously combine between layers to form a complete structure, stable performance, The process of forming molecular aggregates or supramolecular structures with a specific function. The preparation method of layer-by-layer self-assembly is simple, and the preparation process does not require complicated equipment; the film-forming materials are rich, and the polyelectrolyte material can be either natural protein, cellulose, polysaccharide tissue, or artificially synthesized high molecular polymer. In addition, the conditions are controllable, the assembly process is not controlled by the size and material of the substrate, and the structure and properties of the assembly system can be controlled at the molecular level. For example, the invention patent publication CN 113731190 A uses nanocellulose as the membrane-making unit to construct a nanocellulose membrane material with a hydrophilic surface through a layer-by-layer self-assembly method; the invention patent publication CN114292428 A uses a layer-by-layer self-assembly method to construct a nanocellulose membrane material with a hydrophilic surface. The comb polymer quaternized cellulose nanocrystals loaded with hydrophobic antibacterial active substances are combined with the cellulose nanofiber-chitosan base layer to produce an antibacterial film with certain mechanical properties and barrier properties. However, the modification process of the above preparation method is complicated and the long-term stability is poor, which is not conducive to commercial production.
抗菌肽作为一类新兴的抗菌药物,具有高效、绿色、广谱的抗菌性能优势,对部分病毒、细菌、真菌和原虫等均有杀灭作用。一般认为,大多数抗菌肽带有正电荷,通过作用于阴离子细菌膜引发细菌膜电位的破坏、膜通透性的改变和代谢物的渗漏,最终导致细菌死亡。目前,利用抗菌肽制备抗菌抗生物污染膜的研究却鲜有报道。As an emerging class of antibacterial drugs, antimicrobial peptides have the advantages of high-efficiency, green, and broad-spectrum antibacterial properties, and can kill some viruses, bacteria, fungi, and protozoa. It is generally believed that most antimicrobial peptides are positively charged and act on anionic bacterial membranes to cause disruption of bacterial membrane potential, changes in membrane permeability and leakage of metabolites, ultimately leading to bacterial death. At present, there are few reports on the use of antimicrobial peptides to prepare antibacterial and antibiofouling membranes.
发明内容Contents of the invention
本发明的目的是提供一种层层自组装的缓释抗菌聚合物分离膜及其制备方法,改性后的聚合物分离膜抗菌能力和抗污染能力显著提高,对细菌和微生物的繁殖有明显的抑制作用;通过调控反应条件和自组装层数来控制抗菌肽的负载量和释放,从而达到一定的缓释效果。本发明采用层层自组装技术进行抗菌改性,反应温和、操作简单,所制备的聚合物分离膜改性层可调控,具有良好抗菌抗污染性能,在水处理领域具有潜在的广泛应用价值。The purpose of the present invention is to provide a layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and a preparation method thereof. The modified polymer separation membrane has significantly improved antibacterial and anti-pollution capabilities, and has a significant effect on the reproduction of bacteria and microorganisms. The inhibitory effect; by regulating the reaction conditions and the number of self-assembly layers to control the loading and release of antimicrobial peptides, a certain sustained release effect can be achieved. The present invention uses layer-by-layer self-assembly technology for antibacterial modification, with mild reaction and simple operation. The prepared polymer separation membrane modified layer is controllable, has good antibacterial and anti-pollution properties, and has potential wide application value in the field of water treatment.
为了实现上述目的,本发明提供了一种层层自组装的缓释抗菌聚合物分离膜的制备方法,包括如下步骤:In order to achieve the above objects, the present invention provides a method for preparing a layer-by-layer self-assembled slow-release antibacterial polymer separation membrane, which includes the following steps:
步骤1:以聚合物分离膜为基膜,将基膜单面浸泡在多酚类化合物和聚乙烯亚胺的混合溶液中反应,得到表面功能化的基膜,洗干净后待用;Step 1: Use the polymer separation membrane as the base membrane, soak one side of the base membrane in a mixed solution of polyphenol compounds and polyethyleneimine for reaction to obtain a surface functionalized base membrane, wash it clean and set aside for use;
步骤2:将步骤1得到的表面功能化的基膜浸泡于多糖溶液中反应,得到表面有多糖涂层的聚合物分离膜,水洗干净,其中,所述多糖溶液中含有带负电荷的多糖;Step 2: Soak the surface functionalized base membrane obtained in Step 1 into a polysaccharide solution for reaction to obtain a polymer separation membrane with a polysaccharide coating on the surface, and wash it clean with water, wherein the polysaccharide solution contains negatively charged polysaccharides;
步骤3:将抗菌肽溶液与步骤2中所得的表面有多糖涂层的聚合物分离膜反应,形成表面有抗菌肽层的聚合物分离膜,水洗干净,其中,所述抗菌肽溶液中含有带正电荷的抗菌肽;Step 3: React the antimicrobial peptide solution with the polymer separation membrane with a polysaccharide coating on the surface obtained in step 2 to form a polymer separation membrane with an antimicrobial peptide layer on the surface, and wash it clean with water, wherein the antimicrobial peptide solution contains Positively charged antimicrobial peptides;
步骤4:重复步骤2和步骤3若干个循环后,再次重复步骤2,得到最外层为多糖涂层的多糖/抗菌肽层层自组装聚合物分离膜;Step 4: Repeat steps 2 and 3 for several cycles, and then repeat step 2 again to obtain a polysaccharide/antimicrobial peptide layer-by-layer self-assembled polymer separation membrane with a polysaccharide coating as the outermost layer;
步骤5:将步骤4得到的聚合物分离膜浸泡于交联剂溶液中反应,反应结束后,水洗并烘干,得到缓释抗菌聚合物分离膜。Step 5: Soak the polymer separation membrane obtained in Step 4 in the cross-linking agent solution for reaction. After the reaction is completed, wash with water and dry to obtain a sustained-release antibacterial polymer separation membrane.
优选地,所述步骤1中的基膜为PVDF膜、PES膜或PAN膜。Preferably, the base film in step 1 is a PVDF film, PES film or PAN film.
优选地,所述步骤1的混合溶液中多酚类化合物和聚乙烯亚胺的质量浓度为0.1~0.3%,所述混合溶液的pH值为8~9,所述多酚类化合物为多巴胺、儿茶酚和单宁酸中的至少一种。Preferably, the mass concentration of polyphenolic compounds and polyethylenimine in the mixed solution of step 1 is 0.1 to 0.3%, the pH value of the mixed solution is 8 to 9, and the polyphenolic compounds are dopamine, At least one of catechol and tannic acid.
更优选地,所述混合溶液的pH值是采用Tris-HCl缓冲液调节的。More preferably, the pH value of the mixed solution is adjusted using Tris-HCl buffer.
优选地,所述步骤2中的多糖溶液的质量浓度为0.05%~0.5%,所述多糖溶液中含有的多糖为海藻酸钠、硫酸软骨素和硫酸葡聚糖中的至少一种。Preferably, the mass concentration of the polysaccharide solution in step 2 is 0.05% to 0.5%, and the polysaccharide contained in the polysaccharide solution is at least one of sodium alginate, chondroitin sulfate and dextran sulfate.
更优选地,所述多糖溶液的质量浓度为0.05%~0.1%。More preferably, the mass concentration of the polysaccharide solution is 0.05% to 0.1%.
优选地,所述步骤3中抗菌肽溶液的浓度为0.02~1.0g/L,所述抗菌肽溶液的pH值为4.5~6,所述抗菌肽溶液中含有的抗菌肽选自Ponericin G1、Magainin 2和Cecropin B中的至少一种。Preferably, the concentration of the antimicrobial peptide solution in step 3 is 0.02-1.0g/L, the pH value of the antimicrobial peptide solution is 4.5-6, and the antimicrobial peptide contained in the antimicrobial peptide solution is selected from Ponericin G1, Magainin 2 and at least one of Cecropin B.
更优选地,所述抗菌肽溶液是采用醋酸钠缓冲液配制的。More preferably, the antimicrobial peptide solution is prepared using sodium acetate buffer.
优选地,所述步骤5中交联剂溶液的质量浓度为0.5~3%,所述交联剂溶液为CaCl2溶液和MgCl2溶液中的至少一种。Preferably, the mass concentration of the cross-linking agent solution in step 5 is 0.5 to 3%, and the cross-linking agent solution is at least one of CaCl 2 solution and MgCl 2 solution.
优选地,所述步骤1中反应的条件为:在20~30℃下反应3~5h;所述步骤2、3和5中反应的条件为:在20~30℃下反应5~20min。Preferably, the reaction conditions in step 1 are: reaction at 20-30°C for 3-5 hours; the reaction conditions in steps 2, 3 and 5 are: reaction at 20-30°C for 5-20 minutes.
优选地,所述步骤2和步骤3循环的次数为3~30次。Preferably, the number of cycles of step 2 and step 3 is 3 to 30 times.
本发明还提供了上述的制备方法制备得到的缓释抗菌聚合物分离膜。The invention also provides a sustained-release antibacterial polymer separation membrane prepared by the above preparation method.
本发明还提供了上述的缓释抗菌聚合物分离膜在水处理或水处理装置中的应用。The present invention also provides the application of the above-mentioned sustained-release antibacterial polymer separation membrane in water treatment or water treatment devices.
本发明还提供了一种水处理装置,其包括上述的缓释抗菌聚合物分离膜。The present invention also provides a water treatment device, which includes the above-mentioned sustained-release antibacterial polymer separation membrane.
与现有技术相比,本发明的有益效果在于:Compared with the prior art, the beneficial effects of the present invention are:
(1)抗菌肽是一种具有强抗菌作用的阳离子小分子多肽,通过接触致死的方式进行抑菌,具有广谱高效的抑菌效果,本发明的分离膜制备方法创新地采用将抗菌肽作为一种绿色无污染、不引起病菌耐药性的广谱抗菌剂,并利用层层自组装法循环组装抗菌肽和多糖,成功将抗菌功能引入到聚合物分离膜当中,提高了膜的抗菌抗污染性能;(1) Antimicrobial peptides are cationic small molecule polypeptides with strong antibacterial effects. They inhibit bacteria through contact lethality and have broad-spectrum and efficient antibacterial effects. The separation membrane preparation method of the present invention innovatively uses antibacterial peptides as A green, pollution-free, broad-spectrum antibacterial agent that does not cause bacterial resistance. It uses a layer-by-layer self-assembly method to cyclically assemble antibacterial peptides and polysaccharides. It successfully introduces antibacterial functions into polymer separation membranes and improves the antibacterial resistance of the membrane. pollution performance;
(2)本发明利用多糖带负电荷和抗菌肽带正电荷的特性,通过物理吸附和静电作用负载抗菌肽使聚合物分离膜获得抗菌性能,形成的抗菌层厚度可控,不易脱落;(2) The present invention utilizes the negatively charged characteristics of polysaccharides and the positively charged characteristics of antimicrobial peptides to load antimicrobial peptides through physical adsorption and electrostatic interaction so that the polymer separation membrane obtains antimicrobial properties. The thickness of the formed antimicrobial layer is controllable and is not easy to fall off;
(3)本发明制备的聚合物分离膜可以根据改变反应条件和自组装层数来调控抗菌肽的释放速率从而达到延缓释放速率、延长抗菌时间的效果;(3) The polymer separation membrane prepared by the present invention can regulate the release rate of antimicrobial peptides by changing the reaction conditions and the number of self-assembled layers to achieve the effects of delaying the release rate and prolonging the antibacterial time;
(4)本发明改性后的聚合物分离膜具有良好的抗菌性能,对大肠杆菌、金黄色葡萄球菌等微生物具有明显的抑制和杀灭作用;(4) The modified polymer separation membrane of the present invention has good antibacterial properties and has obvious inhibitory and killing effects on microorganisms such as Escherichia coli and Staphylococcus aureus;
(5)本发明制膜工艺简单,易于操作,设备低廉,可控性好,容易工业化实施,且不会明显改变分离膜的透水性能。(5) The membrane production process of the present invention is simple, easy to operate, low-cost equipment, good controllability, easy to implement industrially, and will not significantly change the water permeability of the separation membrane.
附图说明Description of the drawings
图1为采用浊度法测定本发明实施例1制备的聚合物分离膜置于24孔板中后大肠杆菌在培养12h后计算的抗菌效率图;Figure 1 is a graph showing the calculated antibacterial efficiency of Escherichia coli after 12 hours of cultivation using the turbidity method to measure the polymer separation membrane prepared in Example 1 of the present invention after it was placed in a 24-well plate;
图2为实施例1膜M2、M3和M4的膜样品中负载的抗菌肽在PBS溶液中随着时间的释放量;Figure 2 shows the release amount of antimicrobial peptides loaded in the PBS solution over time in the membrane samples of membranes M2, M3 and M4 in Example 1;
图3为实施例4中膜的溶胀度和透水性能随LbL自组装循环数增加的变化情况;Figure 3 shows the changes in swelling degree and water permeability of the membrane as the number of LbL self-assembly cycles increases in Example 4;
图4为实施例5制备的聚合物分离膜置于24孔板中后大肠杆菌在培养12h后计算的抗菌效率图;Figure 4 is a graph showing the calculated antibacterial efficiency of E. coli after culturing for 12 hours after the polymer separation membrane prepared in Example 5 was placed in a 24-well plate;
图5为实施例5膜M5、M6、M7和M8的膜样品中负载的抗菌肽在PBS溶液中随着时间的释放量。Figure 5 shows the release amount of antimicrobial peptides loaded in the PBS solution over time in the membrane samples of membranes M5, M6, M7 and M8 in Example 5.
图6膜的溶胀度和透水性能随着海藻酸钠质量浓度的变化情况。Figure 6 Changes in swelling degree and water permeability of the membrane with the mass concentration of sodium alginate.
具体实施方式Detailed ways
为使本发明更明显易懂,兹以优选实施例,并配合附图作详细说明如下。In order to make the present invention more obvious and understandable, preferred embodiments are described in detail below along with the accompanying drawings.
实施例1Example 1
将PVDF分离膜在清水中浸泡24h,去除PVDF分离膜表面的杂质(记为M0)。将经预处理的分离物膜置于在聚四氟乙烯封闭盒内(单面反应盒),加入1g/L多巴胺和1g/L聚乙烯亚胺,使用Tris-HCl(50mM)调pH=8.5后,置于摇床中,120rmp、20℃条件下反应4h,直至膜上有黄褐色PDA/PEI层。后用去离子水在冲洗三次,用N2吹干,得到多巴胺/聚乙烯亚胺涂覆的PVDF分离膜(记为M1)。配置30mL的0.1wt%的海藻酸钠溶液,再于0.1M醋酸钠缓冲液中配置0.05g/L Ponericin G1得到抗菌肽溶液,然后将得到的多巴胺/聚乙烯亚胺PVDF分离膜交替置于海藻酸钠溶液中反应5min和抗菌肽溶液中反应10min,反应一次便用去离子水清洗1min,重复海藻酸钠和抗菌肽组装10个循环次数后再将膜置于海藻酸钠溶液中反应一次,然后浸入15mL的2wt%的CaCl2溶液中交联10min,用去离子水清洗后,得到抗菌肽/海藻酸钠多层改性PVDF膜(记为M2)。Soak the PVDF separation membrane in clean water for 24 hours to remove impurities on the surface of the PVDF separation membrane (recorded as M0). Place the pretreated separation membrane in a polytetrafluoroethylene closed box (single-sided reaction box), add 1g/L dopamine and 1g/L polyethylenimine, and use Tris-HCl (50mM) to adjust pH = 8.5 Then, place it in a shaker and react for 4 hours at 120 rpm and 20°C until there is a yellow-brown PDA/PEI layer on the membrane. Afterwards, it was rinsed three times with deionized water and dried with N2 to obtain a dopamine/polyethylenimine-coated PVDF separation membrane (marked as M1). Prepare 30mL of 0.1wt% sodium alginate solution, then prepare 0.05g/L Ponericin G1 in 0.1M sodium acetate buffer to obtain an antimicrobial peptide solution, and then place the obtained dopamine/polyethylenimine PVDF separation membrane alternately on the seaweed React in the sodium acid solution for 5 minutes and in the antimicrobial peptide solution for 10 minutes. After one reaction, rinse with deionized water for 1 minute. Repeat the assembly of sodium alginate and antimicrobial peptides for 10 cycles and then place the membrane in the sodium alginate solution for one more reaction. Then it was immersed in 15 mL of 2 wt% CaCl 2 solution for cross-linking for 10 min. After washing with deionized water, an antimicrobial peptide/sodium alginate multilayer modified PVDF membrane (marked as M2) was obtained.
M3:将上述膜与抗菌肽溶液的反应时间改为15min后,重复上述过程,得到不同条件抗菌肽/海藻酸钠多层改性PVDF膜(记为M3)。M3: After changing the reaction time between the above membrane and the antimicrobial peptide solution to 15 minutes, repeat the above process to obtain the antimicrobial peptide/sodium alginate multilayer modified PVDF membrane under different conditions (marked as M3).
M4:保持膜与抗菌肽溶液的反应时间仍为10min,将上述抗菌肽溶液的浓度改为0.1g/L,重复上述过程,得到不同条件抗菌肽/海藻酸钠多层改性PVDF膜(记为M4)。M4: Keep the reaction time between the membrane and the antimicrobial peptide solution at 10 minutes, change the concentration of the above antimicrobial peptide solution to 0.1g/L, repeat the above process, and obtain the antimicrobial peptide/sodium alginate multilayer modified PVDF membrane under different conditions (note for M4).
实施例2Example 2
抗菌性能测试:采用浊度法测定实施例1所制得的膜对大肠杆菌的抗菌性能,操作如下。模型细菌营养肉汤悬液在37℃下培养24h,将培养好的菌液用PBS稀释104倍,得到菌悬液(105cells/mL),然后将膜样品置于24孔板中,每组膜样品3个平行样,加入1mL肉汤培养基、100μL菌液后,置于摇床中在37℃、100rpm条件下培养12h。取出培养液,观察细菌密度,使用酶标仪在对培养液在600nm下比色,并计算其抗菌效率。Antibacterial performance test: The turbidity method was used to determine the antibacterial performance of the membrane prepared in Example 1 against Escherichia coli. The operation was as follows. The model bacterial nutrient broth suspension was cultured at 37°C for 24 hours. The cultured bacterial liquid was diluted 10 4 times with PBS to obtain a bacterial suspension (10 5 cells/mL). Then the membrane sample was placed in a 24-well plate. For each group of membrane samples, 3 parallel samples were added, 1 mL of broth culture medium and 100 μL of bacterial liquid were added, and then placed in a shaker and cultured at 37°C and 100 rpm for 12 hours. Take out the culture medium, observe the bacterial density, use a microplate reader to compare the color of the culture medium at 600nm, and calculate its antibacterial efficiency.
测试结果见图1,可见,实施例1所得的膜M0、M1对大肠杆菌无明显抑制作用,实施例1所得的膜M2对大肠杆菌抑制作用不明显,实施例1所得的膜M3、M4对大肠杆菌具有明显的抑制作用。The test results are shown in Figure 1. It can be seen that the membranes M0 and M1 obtained in Example 1 have no obvious inhibitory effect on E. coli. The membrane M2 obtained in Example 1 has no obvious inhibitory effect on E. coli. The membranes M3 and M4 obtained in Example 1 have no obvious inhibitory effect on E. coli. Escherichia coli has a significant inhibitory effect.
实施例3Example 3
抗菌改性膜中抗菌肽的释放实验:分别选取实施例1所制得的膜M2、M3和M4裁成面积为0.5cm2的膜样品,在24孔板中加入1mL PBS溶液,将膜样品放入溶液中,并置于37℃、100rpm下恒温摇床。分别于1h、2h、4h、8h、12h取出膜样品,对孔中PBS内的抗菌肽进行浓度检测,再将取出的膜样品放入新的1mL PBS中。根据实验结果计算抗菌改性膜中负载的抗菌肽随着时间的释放量。Release experiment of antimicrobial peptides in antibacterial modified membranes: Select membranes M2, M3 and M4 prepared in Example 1 and cut them into membrane samples with an area of 0.5cm2 , add 1mL PBS solution to a 24-well plate, and cut the membrane samples Put it into the solution and place it on a constant temperature shaker at 37°C and 100rpm. Take out the membrane samples at 1h, 2h, 4h, 8h, and 12h respectively, detect the concentration of antimicrobial peptides in the PBS in the wells, and then put the taken out membrane samples into new 1mL PBS. Calculate the release amount of antimicrobial peptides loaded in the antimicrobial modified membrane over time based on the experimental results.
在抗菌肽释放实验中,实施例1制得的膜M2、M3和M4的抗菌肽在2h内释放快速,M2相对M3、M4的释放量较少;实施例1所制得的膜M2中的抗菌肽在4h内基本释放完毕,而膜M3和M4中的抗菌肽在12h内持续释放。可以看出,适当延长膜与抗菌肽溶液的反应时间或者提高抗菌肽溶液的浓度可以提高抗菌肽的负载量。该抗菌肽释放实验与抗菌性能实验结果相对应。In the antimicrobial peptide release experiment, the antimicrobial peptides of the membranes M2, M3 and M4 prepared in Example 1 were rapidly released within 2 hours, and the release amount of M2 was smaller than that of M3 and M4; in the membrane M2 prepared in Example 1, The antimicrobial peptides were basically released within 4 hours, while the antimicrobial peptides in membranes M3 and M4 were continuously released within 12 hours. It can be seen that appropriately extending the reaction time between the membrane and the antimicrobial peptide solution or increasing the concentration of the antimicrobial peptide solution can increase the loading capacity of the antimicrobial peptide. The antimicrobial peptide release experiment corresponds to the antibacterial performance experiment results.
实施例4Example 4
将PVDF分离膜在清水中浸泡24h,去除PVDF分离膜表面的杂质(记为M0)。将经预处理的分离物膜置于在聚四氟乙烯封闭盒内(单面反应盒),加入1g/L多巴胺和1g/L聚乙烯亚胺,使用Tris-HCl(50mM)调pH=8.5后,置于摇床中,120rmp、20℃条件下反应4h,直至膜上有黄褐色PDA/PEI层。后用去离子水在冲洗三次,用N2吹干,得到多巴胺/聚乙烯亚胺涂覆的PVDF分离膜。配置30mL的0.05wt%的海藻酸钠溶液,再于0.1M醋酸钠缓冲液中配置0.05g/LPonericin G1得到抗菌肽溶液(pH=5.1左右),然后将得到的多巴胺/聚乙烯亚胺PVDF分离膜交替置于海藻酸钠溶液中反应5min和抗菌肽溶液中反应10min,反应一次便用去离子水清洗1min,分别重复组装5、10、15、20个循环次数后再将膜置于海藻酸钠溶液中反应一次,然后浸入15mL的2wt%的CaCl2交联10min,清洗后分别得到自组装循环数n=5、10、15、20的抗菌肽/海藻酸钠多层改性PVDF膜(n为LbL自组装循环数)。Soak the PVDF separation membrane in clean water for 24 hours to remove impurities on the surface of the PVDF separation membrane (recorded as M0). Place the pretreated separation membrane in a polytetrafluoroethylene closed box (single-sided reaction box), add 1g/L dopamine and 1g/L polyethylenimine, and use Tris-HCl (50mM) to adjust pH = 8.5 Then, place it in a shaker and react for 4 hours at 120 rpm and 20°C until there is a yellow-brown PDA/PEI layer on the membrane. Then rinse it three times with deionized water and blow dry with N2 to obtain a dopamine/polyethylenimine-coated PVDF separation membrane. Prepare 30mL of 0.05wt% sodium alginate solution, and then prepare 0.05g/LPonericin G1 in 0.1M sodium acetate buffer to obtain an antimicrobial peptide solution (pH = about 5.1), and then separate the obtained dopamine/polyethylenimine PVDF The membrane was alternately placed in the sodium alginate solution for 5 minutes and the antimicrobial peptide solution for 10 minutes. After one reaction, it was washed with deionized water for 1 minute. The assembly was repeated for 5, 10, 15, and 20 cycles before the membrane was placed in alginic acid. React once in sodium solution, and then immerse in 15 mL of 2wt% CaCl 2 for cross-linking for 10 min. After cleaning, antibacterial peptide/sodium alginate multilayer modified PVDF membranes with self-assembly cycle numbers n=5, 10, 15, and 20 were obtained respectively ( n is the number of LbL self-assembly cycles).
溶胀度测试:在25℃下,将2cm×3cm的膜样品在40℃下烘干至恒重,记下质量W0,然后放入去离子水中浸泡24h,捞出用滤纸吸干表面的水分,记下质量W1,按照下列来计算膜溶胀率(swelling ratio,SR):Swelling degree test: At 25°C, dry a 2cm×3cm membrane sample at 40°C to a constant weight, record the mass W 0 , then soak it in deionized water for 24 hours, take it out and use filter paper to absorb the moisture on the surface. , write down the mass W 1 , and calculate the membrane swelling ratio (SR) as follows:
式中,W1和W0分别表示膜在湿态和干态下的质量。根据计算所得的溶胀率来分析比较膜的溶胀情况。In the formula, W 1 and W 0 represent the mass of the film in the wet state and dry state respectively. The swelling of the membranes was analyzed and compared based on the calculated swelling ratio.
结果见图3,从测试结果可以看出,随着LbL自组装循环数量的增加,改性膜的溶胀度逐渐增大。这说明抗菌肽/海藻酸钠多层改性膜随着自组装数的增加,在水中时其表面的水凝胶层会随之增大,从而加强膜的阻隔性能,提高膜的抗污染、抗粘附性。The results are shown in Figure 3. It can be seen from the test results that as the number of LbL self-assembly cycles increases, the swelling degree of the modified membrane gradually increases. This shows that as the self-assembly number of the antimicrobial peptide/sodium alginate multilayer modified membrane increases, the hydrogel layer on its surface will increase when in water, thereby strengthening the barrier performance of the membrane and improving the anti-pollution and anti-pollution properties of the membrane. Anti-adhesion.
透水性能测试:采用死端过滤测试膜的透水性能。将膜样品置于超滤杯,连接好导管,倒入去离子水,调节氮气罐使膜在20kPa的稳定压力下用去离子水预压30min左右,然后测试在一定时间内透过膜的水的体积,直到出水体积保持一致,则表明水通量已稳定。根据J=V/Stp计算出透水性能,其中J为特定压力下膜的透水性能(L/(m2 h·kPa)),V为t时间内透过膜的水的体积(L),S为水透过的膜面积(m2),t为测量时间(h),p为测试时稳定压力(kPa)。Water permeability test: Use dead-end filtration to test the water permeability of the membrane. Place the membrane sample in the ultrafiltration cup, connect the pipe, pour in deionized water, adjust the nitrogen tank so that the membrane is prepressed with deionized water for about 30 minutes under a stable pressure of 20kPa, and then test the water that penetrates the membrane within a certain period of time. volume until the outlet water volume remains consistent, indicating that the water flux has stabilized. The water permeability is calculated according to J=V/Stp, where J is the water permeability of the membrane under a specific pressure (L/(m 2 h·kPa)), V is the volume of water permeating the membrane within t time (L), S is the membrane area through which water passes (m 2 ), t is the measurement time (h), and p is the stable pressure during testing (kPa).
测试结果见图3,从图中可以看出当LbL自组装循环数量在10以下时,抗菌肽/海藻酸钠多层改性膜的透水性能与基膜基本保持一致;反之,其透水性能开始逐渐下降。虽然抗菌肽/海藻酸钠多层改性膜的透水性能会受到组装层数的影响,但即使当LbL自组装循环数为20时,其依然可以保持在基膜的透水性能的74.1%,仍然具有一个良好的透水性能。这说明抗菌肽/海藻酸钠改性层不会明显影响膜的基本性能,相反,可以通过调控LbL自组装循环数量,在不影响膜的基本性能的前提下,能够同时赋予抗菌肽/海藻酸钠多层改性膜优异的抗生物污染性能。The test results are shown in Figure 3. It can be seen from the figure that when the number of LbL self-assembly cycles is less than 10, the water permeability of the antimicrobial peptide/sodium alginate multilayer modified membrane is basically consistent with that of the base film; conversely, its water permeability begins decreasing gradually. Although the water permeability of the antimicrobial peptide/sodium alginate multilayer modified membrane will be affected by the number of assembly layers, even when the number of LbL self-assembly cycles is 20, it can still maintain 74.1% of the water permeability of the base membrane, still Has good water permeability. This shows that the antimicrobial peptide/sodium alginate modified layer will not significantly affect the basic performance of the membrane. On the contrary, by regulating the number of LbL self-assembly cycles, antimicrobial peptides/alginic acid can be simultaneously endowed without affecting the basic performance of the membrane. Sodium multilayer modified membrane has excellent anti-biofouling properties.
实施例5Example 5
将PVDF分离膜在清水中浸泡24h,去除PVDF分离膜表面的杂质(记为M0)。将经预处理的分离物膜置于在聚四氟乙烯封闭盒内(单面反应盒),加入1g/L多巴胺和1g/L聚乙烯亚胺,使用Tris-HCl(50mM)调pH=8.5后,置于摇床中,120rmp、20℃条件下反应4h,直至膜上有黄褐色PDA/PEI层。后用去离子水在冲洗三次,用N2吹干,得到多巴胺/聚乙烯亚胺涂覆的PVDF分离膜。分别配置30mL的0.05wt%浓度的海藻酸钠溶液,再于0.1M醋酸钠缓冲液中配置0.05g/L Ponericin G1得到抗菌肽溶液,然后将得到的多巴胺/聚乙烯亚胺PVDF分离膜交替置于海藻酸钠溶液中反应5min和抗菌肽溶液中反应10min,反应一次便用去离子水清洗1min,分别重复组装5或15个循环次数后再将膜置于海藻酸钠溶液中反应一次,然后浸入15mL的2wt%的CaCl2交联10min,清洗后分别得到自组装循环数n=5、15抗菌肽/海藻酸钠多层改性PVDF膜(记为M5、M6)。Soak the PVDF separation membrane in clean water for 24 hours to remove impurities on the surface of the PVDF separation membrane (recorded as M0). Place the pretreated separation membrane in a polytetrafluoroethylene closed box (single-sided reaction box), add 1g/L dopamine and 1g/L polyethylenimine, and use Tris-HCl (50mM) to adjust pH = 8.5 Then, place it in a shaker and react for 4 hours at 120 rpm and 20°C until there is a yellow-brown PDA/PEI layer on the membrane. Then rinse it three times with deionized water and blow dry with N2 to obtain a dopamine/polyethylenimine-coated PVDF separation membrane. Prepare 30 mL of 0.05wt% sodium alginate solution respectively, and then prepare 0.05g/L Ponericin G1 in 0.1M sodium acetate buffer to obtain an antimicrobial peptide solution, and then place the obtained dopamine/polyethylenimine PVDF separation membranes alternately. React in sodium alginate solution for 5 minutes and antimicrobial peptide solution for 10 minutes. After one reaction, rinse with deionized water for 1 minute. Repeat assembly for 5 or 15 cycles respectively, then place the membrane in sodium alginate solution for one reaction, and then Immerse in 15 mL of 2wt% CaCl 2 for cross-linking for 10 min. After cleaning, self-assembly cycle number n=5 and 15 antimicrobial peptide/sodium alginate multilayer modified PVDF membranes (marked as M5 and M6) were obtained.
将上述海藻酸钠溶液的质量浓度改为0.1wt%,重复上述过程,得到不同条件抗菌肽/海藻酸钠多层改性PVDF膜,将此条件下得到的自组装循环数n=5、15抗菌肽/海藻酸钠多层改性PVDF膜分别记为M7、M8。Change the mass concentration of the above sodium alginate solution to 0.1wt%, repeat the above process, and obtain antimicrobial peptide/sodium alginate multilayer modified PVDF membranes under different conditions. The number of self-assembly cycles obtained under these conditions is n=5, 15 The antimicrobial peptide/sodium alginate multilayer modified PVDF membranes are marked as M7 and M8 respectively.
参照实施例2测试膜的抗菌性能,结果如图4所示,所制得的膜M5、M7对大肠杆菌大肠杆菌抑制作用不明显,而膜M6、M8对大肠杆菌具有明显的抑制作用。可以说明,自组装层数较多时可以保证改性膜具有良好的抗菌效果。The antibacterial performance of the membrane was tested with reference to Example 2. The results are shown in Figure 4. The prepared membranes M5 and M7 had no obvious inhibitory effect on E. coli, while the membranes M6 and M8 had obvious inhibitory effect on E. coli. It can be explained that when the number of self-assembled layers is large, the modified membrane can ensure a good antibacterial effect.
参照实施例5进行抗菌肽的释放实验,结果如图5所示,可以明显看出更多的自组装层数使得改性膜装载的抗菌肽总量更多。该抗菌肽释放实验与抗菌性能实验结果相对应。A release experiment of antimicrobial peptides was performed with reference to Example 5. The results are shown in Figure 5. It can be clearly seen that more self-assembly layers result in a greater total amount of antimicrobial peptides loaded on the modified membrane. The antimicrobial peptide release experiment corresponds to the antibacterial performance experiment results.
实施例6Example 6
将PVDF分离膜在清水中浸泡24h,去除PVDF分离膜表面的杂质(记为M0)。将经预处理的分离物膜置于在聚四氟乙烯封闭盒内(单面反应盒),加入1g/L多巴胺和1g/L聚乙烯亚胺,使用Tris-HCl(50mM)调pH=8.5后,置于摇床中,120rmp、20℃条件下反应4h,直至膜上有黄褐色PDA/PEI层。后用去离子水在冲洗三次,用N2吹干,得到多巴胺/聚乙烯亚胺涂覆的PVDF分离膜。配置30mL的0.5wt%浓度的海藻酸钠溶液,再于0.1M醋酸钠缓冲液中配置0.05g/L Ponericin G1得到抗菌肽溶液,然后将得到的多巴胺/聚乙烯亚胺PVDF分离膜交替置于海藻酸钠溶液中反应5min和抗菌肽溶液中反应10min,反应一次便用去离子水清洗1min,分别重复组装5个循环次数后再将膜置于海藻酸钠溶液中反应一次,然后浸入15mL的2wt%的CaCl2交联10min,清洗后得到0.5wt%海藻酸钠浓度下自组装循环数n=5的抗菌肽/海藻酸钠多层改性PVDF膜。Soak the PVDF separation membrane in clean water for 24 hours to remove impurities on the surface of the PVDF separation membrane (recorded as M0). Place the pretreated separation membrane in a polytetrafluoroethylene closed box (single-sided reaction box), add 1g/L dopamine and 1g/L polyethylenimine, and use Tris-HCl (50mM) to adjust pH = 8.5 Then, place it in a shaker and react for 4 hours at 120 rpm and 20°C until there is a yellow-brown PDA/PEI layer on the membrane. Then rinse it three times with deionized water and blow dry with N2 to obtain a dopamine/polyethylenimine-coated PVDF separation membrane. Prepare 30mL of 0.5wt% sodium alginate solution, and then prepare 0.05g/L Ponericin G1 in 0.1M sodium acetate buffer to obtain an antimicrobial peptide solution, and then place the obtained dopamine/polyethylenimine PVDF separation membrane alternately React in sodium alginate solution for 5 minutes and antimicrobial peptide solution for 10 minutes. After one reaction, rinse with deionized water for 1 minute. Repeat assembly for 5 cycles, then place the membrane in sodium alginate solution for one reaction, and then immerse in 15 mL of Cross- linked with 2wt% CaCl for 10 minutes, and after cleaning, an antimicrobial peptide/sodium alginate multilayer modified PVDF membrane with a self-assembly cycle number n=5 at a concentration of 0.5wt% sodium alginate was obtained.
参照实施例4的测试方法测试膜的溶胀度和透水性能。测试结果见图6,从图中可以看抗菌肽/海藻酸钠多层改性膜的溶胀度和透水性能受到海藻酸钠质量浓度的影响,当海藻酸钠质量浓度为0.05wt%时,改性膜的透水性能的影响较小;当浓度为0.5wt%时,其透水性能降低到基膜的三分之一,很大程度地影响了膜的基本性能。故海藻酸钠溶液的质量浓度优选为0.05wt%~0.1wt%。Refer to the test method of Example 4 to test the swelling degree and water permeability of the membrane. The test results are shown in Figure 6. It can be seen from the figure that the swelling degree and water permeability of the antimicrobial peptide/sodium alginate multilayer modified membrane are affected by the mass concentration of sodium alginate. When the mass concentration of sodium alginate is 0.05wt%, the modified membrane The water permeability of the base film has little impact; when the concentration is 0.5wt%, its water permeability is reduced to one-third of that of the base film, which greatly affects the basic performance of the membrane. Therefore, the mass concentration of the sodium alginate solution is preferably 0.05wt% to 0.1wt%.
上述实施例仅为本发明的优选实施例,并非对本发明任何形式上和实质上的限制,应当指出,对于本技术领域的普通技术人员,在不脱离本发明的前提下,还将可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。The above embodiments are only preferred embodiments of the present invention, and do not limit the present invention in any form or substance. It should be pointed out that those of ordinary skill in the art can also make other modifications without departing from the present invention. There are several improvements and supplements, which should also be considered as the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210613901.2A CN114904402B (en) | 2022-06-01 | 2022-06-01 | A layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210613901.2A CN114904402B (en) | 2022-06-01 | 2022-06-01 | A layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114904402A CN114904402A (en) | 2022-08-16 |
CN114904402B true CN114904402B (en) | 2024-01-16 |
Family
ID=82771637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210613901.2A Active CN114904402B (en) | 2022-06-01 | 2022-06-01 | A layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114904402B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116465940B (en) * | 2023-04-21 | 2024-12-10 | 青岛科技大学 | A flexible anti-pollution porous film and its preparation method and application |
CN116655983B (en) * | 2023-05-24 | 2025-01-28 | 浙江和顺新材料有限公司 | Antistatic and antibacterial biaxially stretched polyester composite film and preparation method thereof |
CN116808302A (en) * | 2023-06-30 | 2023-09-29 | 征鸿诺瓦医疗科技(深圳)有限公司 | Preparation method and application of substrate surface layer-by-layer electrostatic assembly coating |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456233A (en) * | 2015-11-17 | 2016-04-06 | 中国石油大学(华东) | High-drug-loading-capacity long-effect slow-release antibacterial thin film and preparation method thereof |
CN112108012A (en) * | 2020-09-29 | 2020-12-22 | 湖南澳维环保科技有限公司 | Antibacterial polyamide reverse osmosis composite membrane and preparation method thereof |
-
2022
- 2022-06-01 CN CN202210613901.2A patent/CN114904402B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456233A (en) * | 2015-11-17 | 2016-04-06 | 中国石油大学(华东) | High-drug-loading-capacity long-effect slow-release antibacterial thin film and preparation method thereof |
CN112108012A (en) * | 2020-09-29 | 2020-12-22 | 湖南澳维环保科技有限公司 | Antibacterial polyamide reverse osmosis composite membrane and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114904402A (en) | 2022-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114904402B (en) | A layer-by-layer self-assembled slow-release antibacterial polymer separation membrane and its preparation method and application | |
CN109499370B (en) | Method for ZIF-8 in situ growth modified polyethersulfone forward osmosis membrane and obtained membrane | |
CN107875868B (en) | A kind of composite nanofiltration membrane of phenolamine alternately assembled and preparation method thereof | |
CN106977757A (en) | Preparation method of dopamine silk gum laminated film of Nano Silver functionalization and products thereof and application | |
CN107149885A (en) | A kind of preparation method of antibacterial stable against biological contamination polymer separation film | |
CN103349922B (en) | Method of surface functionalization of aramatic polyamides reverse osmosis thin film composite membrane | |
CN105727773A (en) | Anti-bacterial and anti-pollution polymer separation membrane and preparation method thereof | |
CN112237853B (en) | Antibacterial and anti-pollution microporous membrane and preparation method thereof | |
CN112221354A (en) | Antibacterial and anti-pollution microporous membrane based on Michael addition reaction and preparation method thereof | |
CN103316599A (en) | Preparation method of glycine betaine colloid nano particle modified chitosan nanofiltration membrane | |
CN106178994A (en) | A kind of preparation method of antibacterial NF membrane | |
Fang et al. | Intrinsically antibacterial thin film composite membranes with supramolecularly assembled lysozyme nanofilm as selective layer for molecular separation | |
CN114702708B (en) | Antibacterial material with wide pH application range and preparation method and application thereof | |
CN106955603A (en) | A kind of surface segregation functionalization antipollution polymer separation film and preparation method thereof | |
CN114887494B (en) | Preparation method and application of metal ion leaching-free release-type MIL-53 modified membrane | |
CN105597578B (en) | A kind of directional induction loading nano silvery antibacterial seperation film and preparation method thereof | |
CN110124537A (en) | The preparation method of composite polysulfone membrane and its purposes in marine culture wastewater processing | |
CN110628071A (en) | A kind of antibacterial degradable polymer and its preparation method and application | |
CN114377563B (en) | Preparation method of polyion liquid brush surface grafting modified anti-biological pollution PVDF ultrafiltration membrane | |
CN112293416B (en) | Environment-friendly non-release CS-b-PEG (polyethylene glycol) antibacterial micelle and preparation method thereof | |
CN116943463A (en) | Anti-pollution polymer separation membrane with surface-fixed antimicrobial peptides and preparation method thereof | |
JP4522707B2 (en) | Microbial scavenger | |
CN115245168A (en) | A kind of long-acting antibacterial agent suitable for various substrates, preparation method and application thereof | |
CN115634576A (en) | Preparation method of organic solvent nanofiltration membrane | |
CN102746477A (en) | Fluorine-containing amphiphilic modification material used for preparation of membrane with excellent performances and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |